We are live on ! Find out more
NRC

North Run Capital Portfolio holdings

AUM $43.5M
1-Year Est. Return 38.24%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
-38.24%
3 Year Est. Return
+19.43%
5 Year Est. Return
+17.57%
10 Year Est. Return
AUM
$789M
AUM Growth
+$21.4M
Cap. Flow
+$6.25M
Cap. Flow %
0.79%
Top 10 Hldgs %
74.12%
Holding
30
New
4
Increased
6
Reduced
13
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 43.51%
2 Consumer Discretionary 18.62%
3 Financials 16.24%
4 Industrials 9.81%
5 Materials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$40.8B
$94.2M 11.93%
+2,350,000
New +$92.5M
HNT
2
DELISTED
HEALTH NET INC
HNT
$70.3M 8.91%
2,370,000
-405,000
-15% -$12.1M
AET
3
DELISTED
Aetna Inc
AET
$68.6M 8.69%
1,000,000
+25,000
+3% +$1.63M
BKD icon
4
Brookdale Senior Living
BKD
$3.49B
$66.9M 8.48%
2,462,969
+212,969
+9% +$5.9M
HSP
5
DELISTED
HOSPIRA INC
HSP
$56.3M 7.14%
1,365,000
-85,000
-6% -$3.42M
ATI icon
6
ATI
ATI
$25.6B
$55.2M 7%
1,550,000
-450,000
-23% -$14.8M
GM icon
7
General Motors
GM
$80.4B
$45.2M 5.72%
1,105,000
-365,000
-25% -$13.8M
HRB icon
8
H&R Block
HRB
$5.58B
$44.8M 5.67%
+1,542,000
New +$43.8M
MOS icon
9
The Mosaic Company
MOS
$7.03B
$42.3M 5.36%
895,000
+295,000
+49% +$13.7M
ETFC
10
DELISTED
E*Trade Financial Corporation
ETFC
$41.2M 5.22%
+2,098,894
New +$37.3M
BSX icon
11
Boston Scientific
BSX
$69.5B
$39.5M 5%
3,285,000
-1,215,000
-27% -$14.4M
QVCGA
12
DELISTED
QVC Group Inc Series A
QVCGA
$28.2M 3.57%
23,375
-28,713
-55% -$31.9M
ACTG icon
13
Acacia Research
ACTG
$428M
$22.2M 2.82%
1,528,524
-601,476
-28% -$9.5M
GTS
14
DELISTED
Triple-S Management Corporation
GTS
$18.4M 2.33%
994,747
-711,884
-42% -$12.7M
NWY
15
DELISTED
New York & Co Inc
NWY
$17.5M 2.21%
3,995,973
-478,027
-11% -$2.39M
MCGC
16
DELISTED
MCG CAP CORP
MCGC
$12.7M 1.61%
2,896,464
-353,536
-11% -$1.69M
NDZ
17
DELISTED
NORDION INC COM STK (CDA)
NDZ
$12M 1.52%
1,414,200
NRF
18
DELISTED
NorthStar Realty Finance Corp.
NRF
$11.6M 1.47%
+440,583
New +$8.9M
LORL
19
DELISTED
Loral Space and Communications, Inc.
LORL
$11.6M 1.47%
143,035
-246,965
-63% -$18M
LOV
20
DELISTED
Spark Networks SE American Depositary Shares
LOV
$11.4M 1.45%
1,855,856
+125,101
+7% +$835K
EYPT icon
21
EyePoint Inc
EYPT
$1.03B
$8.51M 1.08%
214,409
+26,185
+14% +$850K
ALIM
22
DELISTED
Alimera Sciences
ALIM
$7.69M 0.97%
108,891
-17,776
-14% -$724K
DLIA
23
DELISTED
DELIA*S INC
DLIA
$2.75M 0.35%
3,122,564
+524,516
+20% +$627K
BODY
24
DELISTED
BODY CENTRAL CORP COM STK
BODY
$195K 0.02%
49,542
-1,103,251
-96% -$4.78M
VRNT
25
DELISTED
Verint Systems
VRNT
-1,177,800
Closed -$22.2M

Similar funds

North Run Capital's Q4 2013 Portfolio in Review

As of Q4 2013, North Run Capital held 30 positions worth $789M, up 2.8% from $768M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

North Run Capital's Q4 2013 filing shows 4 new, 6 increased, 13 reduced and 6 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,350,000 shares worth $94.2M. The largest sale was QVC Group Inc Series A, an estimated $31.9M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

  • North Run Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 2,350,000 shares worth $94.2M.
  • North Run Capital added most to The Mosaic Company in Q4 2013, an estimated $13.7M increase.
  • North Run Capital's biggest Q4 2013 reduction was QVC Group Inc Series A, cutting an estimated $31.9M.
  • North Run Capital fully exited Verint Systems in Q4 2013, selling an estimated $22.2M.
  • North Run Capital's ten largest holdings make up 74% of its $789M portfolio in Q4 2013.
  • North Run Capital opened 4 new positions and closed 6 in Q4 2013.
  • North Run Capital's portfolio value rose 2.8% quarter-over-quarter to $789M.

Based on North Run Capital's 13F filing for Q4 2013, filed 14 Feb 2014.